The UK Health Security Agency (UKHSA) has identified a new recombinant mpox virus in England in an individual who had recently travelled to Asia.
Features
Hyperviscosity syndrome: a complication hiding in plain sight?
David Manuel, David Norcliffe and Bernie Benson present a study of hyperviscosity syndrome, looking at its associated primary causes, along with the effects, symptoms and laboratory testing of this critical medical condition.
Detection to direction: the future of precision oncology diagnostics
Advances in molecular and genomic technologies are transforming oncology diagnostics, bridging screening, risk stratification, and treatment selection into a connected model of early cancer detection.
Products
ProtonDx's Dragonfly evaluated for identifying hidden malaria cases
A new study has shown that Dragonfly, a low-cost, rapid, molecular testing platform is successfully able to detect asymptomatic malaria infections.
New blood-based assay for Alzheimer's disease research
Precision proteomics firm Alamar Biosciences has announced the launch of the NULISAqpcr BD-pTau217 Assay, which it says is a transformative leap in blood-based quantification of brain-derived phosphorylated tau 217 (pTau217)—a pivotal biomarker in Alzheimer's disease research and other tauopathies.
Ten-colour PCR platform bridges gap between PCR and NGS
Countable Labs has announced the launch of Countable 10, the first and only PCR platform capable of 10-color multiplexing. The new platform will extend the utility of the company’s core Countable PCR technology to enable higher level multiplexing that easily and cleanly reveals more insights in a single reaction.
Gestalt launches PathFlow update
Gestalt has announced the release of PathFlow Version 6, the latest evolution of its award-winning digital pathology platform.
Latest Issues
Epredia was established in July 2019 through the acquisition by PHC Group of the Anatomical Pathology division of Thermo Fisher Scientific. Our name has changed, however as a standalone business our mission remains the same: to improve lives by enhancing cancer diagnostics.
We are powered by the quality brands you know and trust, such as...
Fresh muscle biopsies webinar
Online
11 December, 2025
POCT Innovators - The power to disrupt through diagnostics
National Army Museum, Chelsea, London
15 December, 2025
RSM / Path Soc 2026 Winter Meeting
The Royal Society of Medicine, 1 Wimpole St, London, W1G 0AE
20 - 21 January, 2026
BIVDA Regulatory Affairs Seminar
Grand Hotel, Birmingham
10 - 11 February, 2026
BDIAP Molecular Pathology Study Day
10 Union Street, London, SE1 1SZ
2 March, 2026